dipyrone and Diabetes Mellitus, Adult-Onset

dipyrone has been researched along with Diabetes Mellitus, Adult-Onset in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaku, K; Kisanuki, K; Oohira, T; Shibata, M1
Garcipérez de Vargas, FJ; Mendoza, J; Mogollón-Jiménez, MV; Ortiz, C; Porro, R; Sánchez-Calderón, P1
Hoffmann, A; Lautenschlager, MT; Müller, UA; Viktor, S1

Reviews

1 review(s) available for dipyrone and Diabetes Mellitus, Adult-Onset

ArticleYear
Benefit-Risk Assessment of Alogliptin for the Treatment of Type 2 Diabetes Mellitus.
    Drug safety, 2019, Volume: 42, Issue:11

    Topics: Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Dipyrone; Humans; Hypoglycemic Agents; Risk Assessment

2019

Trials

1 trial(s) available for dipyrone and Diabetes Mellitus, Adult-Onset

ArticleYear
[Comparison of serum concentrations of caffeine, 4-methylaminoantipyrine, sulfamethazine and debrisoquin following oral administration of these substances as a cocktail in type II diabetics before and after insulin therapy].
    Die Pharmazie, 1996, Volume: 51, Issue:10

    Topics: Adult; Aged; Anti-Infective Agents; Caffeine; Central Nervous System Stimulants; Cytochrome P-450 Enzyme System; Debrisoquin; Diabetes Mellitus, Type 2; Dipyrone; Drug Combinations; Female; Humans; Hypoglycemic Agents; Insulin; Isoenzymes; Male; Middle Aged; Pyrazolones; Sulfamethazine; Sympatholytics

1996

Other Studies

1 other study(ies) available for dipyrone and Diabetes Mellitus, Adult-Onset

ArticleYear
Cardiogenic shock secondary to metamizole-induced type II Kounis syndrome.
    Revista espanola de cardiologia (English ed.), 2012, Volume: 65, Issue:12

    Topics: Acute Coronary Syndrome; Anti-Inflammatory Agents, Non-Steroidal; Coronary Vasospasm; Diabetes Mellitus, Type 2; Dipyrone; Drug Hypersensitivity; Drug-Eluting Stents; Electrocardiography; Female; Humans; Middle Aged; Shock, Cardiogenic; Syndrome

2012